Does Native Vitamin D Supplementation Have Pleiotropic Effects in Patients with End-Stage Kidney Disease? A Systematic Review of Randomized Trials
暂无分享,去创建一个
R. Holden | Angélique Roy | Nathan G. Pilkey | Michael A. Adams | Sono S. Khan | Olivia Novosel | Tristin E. Wilson | Jaya Sharma | Sanjana Kapuria | Jaya K Sharma | Sono Khan
[1] P. Dehghan,et al. Efficacy of vitamin D supplementation as an adjunct therapy for improving inflammatory and oxidative stress biomarkers: An umbrella meta-analysis. , 2022, Pharmacological research.
[2] Zheran Liu,et al. Association of Vitamin D Supplementation with Cardiovascular Events: A Systematic Review and Meta-Analysis , 2022, Nutrients.
[3] Rosemarie Derwin,et al. What is the impact of daily oral supplementation of vitamin D3 (cholecalciferol) plus calcium on the incidence of hip fracture in older people? A systematic review and meta‐analysis , 2022, International journal of older people nursing.
[4] M. Petkovich,et al. The metabolism of 1,25(OH)2D3 in clinical and experimental kidney disease , 2022, Scientific Reports.
[5] Dana Ahmed Sharif. The Effectiveness of Vitamin D Supplementation on Oxidative and Inflammatory Markers in Patients Suffering from End-stage Renal Disease, a Randomized Controlled Trial. , 2022, Cellular and molecular biology.
[6] F. Baig,et al. Outcome of Cholecalciferol Supplementation on Bone Mineral metabolism in End Stage Renal Disease Patients in Comparison with Placebo- Randomized Control Trial , 2022, Pakistan Journal of Medical and Health Sciences.
[7] Arsh K Jain,et al. Impact of Bioelectrical Impedance-Guided Fluid Management and Vitamin D Supplementation on Left Ventricular Mass in Patients Receiving Peritoneal Dialysis: A Randomized Controlled Trial. , 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[8] A. Santoro,et al. Calcifediol supplementation in adults on hemodialysis: a randomized controlled trial , 2021, Journal of Nephrology.
[9] G. Stangl,et al. Serum Testosterone Levels Are Not Modified by Vitamin D Supplementation in Dialysis Patients and Healthy Subjects , 2021, Nephron.
[10] D. Fliser,et al. Cardiovascular Disease in Chronic Kidney Disease , 2021, Circulation.
[11] A. Stinghen,et al. In vitro anti-inflammatory effects of vitamin D supplementation may be blurred in hemodialysis patients , 2021, Clinics.
[12] E. Mayo-Wilson,et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2020, BMJ.
[13] Expression of Concern: The Effects of Vitamin D Supplementation on Signaling Pathway of Inflammation and Oxidative Stress in Diabetic Hemodialysis: A Randomized, Double-Blind, Placebo-Controlled Trial , 2020, Frontiers in Pharmacology.
[14] R. Mustafa,et al. Canadian Society of Nephrology Commentary on the Kidney Disease Improving Global Outcomes 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder , 2020, Canadian journal of kidney health and disease.
[15] Natalie S Blencowe,et al. RoB 2: a revised tool for assessing risk of bias in randomised trials , 2019, BMJ.
[16] Yu Zhang,et al. Association between vitamin D supplementation and mortality: systematic review and meta-analysis , 2019, BMJ.
[17] Mary Edwards,et al. Translating the Cochrane EMBASE RCT filter from the Ovid interface to Embase.com: a case study. , 2019, Health information and libraries journal.
[18] B. Stengel,et al. Pruritus and Patient Reported Outcomes in Non-Dialysis CKD. , 2019, Clinical journal of the American Society of Nephrology : CJASN.
[19] W. Winkelmayer,et al. Economic and quality of life burden of anemia on patients with CKD on dialysis: a systematic review , 2019, Journal of medical economics.
[20] Shi-kun Yang,et al. Effects of Vitamin D Supplementation on Renal Function, Inflammation and Glycemic Control in Patients with Diabetic Nephropathy: a Systematic Review and Meta-Analysis , 2019, Kidney and Blood Pressure Research.
[21] Y. Bentata. Benefit–risk balance of native vitamin D supplementation in chronic hemodialysis: what can we learn from the major clinical trials and international guidelines? , 2019, Renal failure.
[22] David W. Johnson,et al. Vitamin D status and mortality risk among patients on dialysis: a systematic review and meta-analysis of observational studies , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[23] G. Walters,et al. Placebo-controlled, randomized clinical trial of high-dose cholecalciferol in renal dialysis patients: effect on muscle strength and quality of life , 2018, Clinical kidney journal.
[24] M. Mansournia,et al. The Effects of Vitamin D Supplementation on Biomarkers of Inflammation and Oxidative Stress in Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2018, Hormone and Metabolic Research.
[25] D. Bikle,et al. Physiologic and pathophysiologic roles of extra renal CYP27b1: Case report and review , 2018, Bone reports.
[26] C. Zheng,et al. Cholecalciferol Additively Reduces Serum Parathyroid Hormone Levels in Severe Secondary Hyperparathyroidism Treated with Calcitriol and Cinacalcet among Hemodialysis Patients , 2018, Nutrients.
[27] Z. Asemi,et al. Note of Concern: Clinical Trial on the Effects of Vitamin D Supplementation on Metabolic Profiles in Diabetic Hemodialysis , 2018, Hormone and Metabolic Research.
[28] T. Hasegawa,et al. International Comparisons of Prevalence, Awareness, and Treatment of Pruritus in People on Hemodialysis. , 2017, Clinical journal of the American Society of Nephrology : CJASN.
[29] Mary B Leonard,et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters. , 2017, Kidney international.
[30] L. Cuppari,et al. Effect of cholecalciferol on vitamin D-regulatory proteins in monocytes and on inflammatory markers in dialysis patients: A randomized controlled trial. , 2016, Clinical nutrition.
[31] H. Tighiouart,et al. Ergocalciferol Supplementation in Hemodialysis Patients With Vitamin D Deficiency: A Randomized Clinical Trial. , 2016, Journal of the American Society of Nephrology : JASN.
[32] Ying Wang,et al. Efficacy of High-Dose Supplementation With Oral Vitamin D3 on Depressive Symptoms in Dialysis Patients With Vitamin D3 Insufficiency: A Prospective, Randomized, Double-Blind Study , 2016, Journal of clinical psychopharmacology.
[33] Chen Xu,et al. Evaluation of responses to vitamin D3 (cholecalciferol) in patients on dialysis: a systematic review and meta-analysis , 2016, Journal of Investigative Medicine.
[34] R. Payne,et al. Using the UK renal registry for a clinical trial in dialysis patients: the example of SIMPLIFIED , 2015, Trials.
[35] A. Honig,et al. Association of depressive and anxiety symptoms with adverse events in Dutch chronic kidney disease patients: a prospective cohort study , 2015, BMC Nephrology.
[36] A. Pezeshki,et al. The effect of Vitamin D administration on treatment of anemia in end-stage renal disease patients with Vitamin D deficiency on hemodialysis: A placebo-controlled, double-blind clinical trial , 2015, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.
[37] M. Jensen,et al. Vitamin D is associated with testosterone and hypogonadism in Chinese men: Results from a cross-sectional SPECT-China study , 2015, Reproductive Biology and Endocrinology.
[38] B. Timar,et al. Vitamin D Deficiency—Prognostic Marker or Mortality Risk Factor in End Stage Renal Disease Patients with Diabetes Mellitus Treated with Hemodialysis—A Prospective Multicenter Study , 2015, PloS one.
[39] I. Bhan,et al. Nutritional vitamin D supplementation in dialysis: a randomized trial. , 2015, Clinical journal of the American Society of Nephrology : CJASN.
[40] S. Seirafian,et al. The effect of oral vitamin D on serum level of N-terminal pro-B-type natriuretic peptide , 2014, Advanced biomedical research.
[41] S. Niemczyk,et al. Long-Term Cholecalciferol Administration in Hemodialysis Patients: A Single-Center Randomized Pilot Study , 2014, Medical science monitor : international medical journal of experimental and clinical research.
[42] I. Reid,et al. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. , 2014, The lancet. Diabetes & endocrinology.
[43] J. Bech,et al. Cardiovascular effects of cholecalciferol treatment in dialysis patients – a randomized controlled trial , 2014, BMC Nephrology.
[44] Yize Zhao,et al. Very High-dose Cholecalciferol and Arteriovenous Fistula Maturation in ESRD: A Randomized, Double-blind, Placebo-Controlled Pilot Study , 2014, The journal of vascular access.
[45] Zhenfeng Zheng,et al. Vitamin D supplementation and mortality risk in chronic kidney disease: a meta-analysis of 20 observational studies , 2013, BMC Nephrology.
[46] J. Carrero,et al. Endogenous testosterone, muscle strength, and fat-free mass in men with chronic kidney disease. , 2013, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
[47] G. Heine,et al. Influence of Cholecalciferol Supplementation in Hemodialysis Patients on Monocyte Subsets: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial , 2013, Nephron Clinical Practice.
[48] G. Elder,et al. Effects of cholecalciferol on functional, biochemical, vascular, and quality of life outcomes in hemodialysis patients. , 2013, Clinical journal of the American Society of Nephrology : CJASN.
[49] E. Cavalier,et al. Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[50] S. Fishbane,et al. The effect of ergocalciferol on uremic pruritus severity: a randomized controlled trial. , 2013, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
[51] L. De Nicola,et al. Renal anaemia and EPO hyporesponsiveness associated with vitamin D deficiency: the potential role of inflammation. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[52] G. Hudes,et al. Translational Science 2013 Abstracts , 2013 .
[53] R. Pecoits-Filho,et al. Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism. , 2012, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
[54] D. Riches,et al. Vitamin D Inhibits Monocyte/Macrophage Proinflammatory Cytokine Production by Targeting MAPK Phosphatase-1 , 2012, The Journal of Immunology.
[55] Lorien S. Dalrymple,et al. Vitamin D deficiency, self-reported physical activity and health-related quality of life: the Comprehensive Dialysis Study. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[56] M. Olandoski,et al. Hypovitaminosis D Is Associated with Systemic Inflammation and Concentric Myocardial Geometric Pattern in Hemodialysis Patients with Low iPTH Levels , 2011, Nephron Clinical Practice.
[57] Aníbal Ferreira,et al. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[58] W. März,et al. Association of vitamin D status with serum androgen levels in men , 2009, Clinical endocrinology.
[59] S. Arver,et al. Low serum testosterone increases mortality risk among male dialysis patients. , 2009, Journal of the American Society of Nephrology : JASN.
[60] Alan Bensoussan,et al. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis , 2007, The Lancet.
[61] D. Oliver,et al. Vitamin D Insufficiency and Deficiency in Chronic Kidney Disease , 2004, American Journal of Nephrology.
[62] S. Fukuhara,et al. Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). , 2003, Kidney international.
[63] P. Khajehdehi. Effect of Vitamins on the Lipid Profile of Patients on Regular Hemodialysis , 2000, Scandinavian journal of urology and nephrology.
[64] A. Menter,et al. Uremic pruritus: skin divalent ion content and response to ultraviolet phototherapy. , 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[65] K. Arndt,et al. Relief of uremic pruritus with ultraviolet phototherapy. , 1977, The New England journal of medicine.
[66] P. Dhawan,et al. Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. , 2016, Physiological reviews.
[67] D. Bikle. Nonclassic actions of vitamin D. , 2009, The Journal of clinical endocrinology and metabolism.
[68] C. Zoccali,et al. Vitamin D levels and patient outcome in chronic kidney disease. , 2009, Kidney international.
[69] Hirokazu Honda,et al. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[70] Abstracts of the American Society of Nephrology 2003 Renal Week. November 12-17, 2003. San Diego, California, USA. , 2003, Journal of the American Society of Nephrology : JASN.
[71] M. Cowie,et al. BNP and congestive heart failure. , 2002, Progress in cardiovascular diseases.